| Trial ID: | L4334 |
| Source ID: | NCT00657319
|
| Associated Drug: |
Biphasic Insulin Aspart 30
|
| Title: |
Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: biphasic insulin aspart 30
|
| Outcome Measures: |
Primary: HbA1C, 6 months | Secondary: General conditions (reason of switch, BMI, selected laboratory parameters, quality of care), 6 months
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
3495
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-10
|
| Completion Date: |
2008-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-09
|
| Locations: |
Novo Nordisk Investigational Site, Budapest, 1025, Hungary
|
| URL: |
https://clinicaltrials.gov/show/NCT00657319
|
